Maj Invest Holding A/S’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104K Buy
1,490
+500
+51% +$25.9K ﹤0.01% 32
2026
Q1
$50K Hold
990
﹤0.01% 38
2025
Q4
$29K Hold
990
﹤0.01% 38
2025
Q3
$26K Hold
990
﹤0.01% 42
2025
Q2
$28K Hold
990
﹤0.01% 42
2025
Q1
$28K Hold
990
﹤0.01% 43
2024
Q4
$41K Hold
990
﹤0.01% 38
2024
Q3
$66K Hold
990
﹤0.01% 37
2024
Q2
$118K Hold
990
﹤0.01% 27
2024
Q1
$106K Hold
990
﹤0.01% 29
2023
Q4
$99K Hold
990
﹤0.01% 31
2023
Q3
$102K Hold
990
﹤0.01% 28
2023
Q2
$120K Hold
990
﹤0.01% 27
2023
Q1
$153K Hold
990
﹤0.01% 26
2022
Q4
$177K Buy
990
+570
+136% +$93.2K ﹤0.01% 23
2022
Q3
$50K Sell
420
-570
-58% -$86.5K ﹤0.01% 26
2022
Q2
$141K Hold
990
﹤0.01% 24
2022
Q1
$170K Hold
990
﹤0.01% 23
2021
Q4
$252K Hold
990
﹤0.01% 21
2021
Q3
$381K Sell
990
-410
-29% -$151K 0.01% 19
2021
Q2
$329K Hold
1,400
0.01% 23
2021
Q1
$184K Buy
+1,400
New +$203K ﹤0.01% 24

Other funds holding MRNA

Maj Invest Holding A/S's MRNA Position: Q2 2026 in Review

Maj Invest Holding A/S increased its Moderna (MRNA) stake by 51% in Q2 2026, buying an estimated $25.9K and bringing the position to 1,490 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #32.

Maj Invest Holding A/S first reported a position in MRNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $381K in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Maj Invest Holding A/S held 1,490 shares of Moderna worth $104K as of Q2 2026.
  • Maj Invest Holding A/S bought 500 Moderna shares in Q2 2026, an estimated $25.9K.
  • Moderna made up ﹤0.01% of Maj Invest Holding A/S's portfolio in Q2 2026, its #32 holding.
  • Maj Invest Holding A/S first reported a position in Moderna in Q1 2021 and has held it in 22 quarters since.
  • Maj Invest Holding A/S's Moderna position peaked at $381K in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Maj Invest Holding A/S's 13F filing for Q2 2026, filed 9 Jul 2026.